Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

DTHIB is an inhibitor of heat shock factor 1 (Hsf1).1 It binds to the DNA-binding domain of Hsf1 (Kd = 160 nM) and inhibits heat-induced increases in the Hsf1 target proteins heat shock protein 27 (Hsp27) and Hsp70 levels in mouse embryonic fibroblasts (MEFs) when used at a concentration of 10 µM. It decreases nuclear but not cytoplasmic levels of Hsf1 in C4-2 prostate cancer cells, an effect that can be blocked by the proteasome inhibitor MG132. DTHIB decreases the viability of 22Rv1, C4-2, and PC3 prostate cancer cells (EC50 = 1.6, 1.2, and 3 µM, respectively) and induces cell cycle arrest at the G1 phase in C4-2 cells. In vivo, DTHIB (5 mg/kg) induces tumor regression in a TRAMP-C2 murine prostate cancer model.
WARNING This product is not for human or veterinary use.
1. Targeting therapy-